David A. Long

5.9k total citations · 1 hit paper
90 papers, 3.7k citations indexed

About

David A. Long is a scholar working on Molecular Biology, Nephrology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, David A. Long has authored 90 papers receiving a total of 3.7k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Molecular Biology, 22 papers in Nephrology and 13 papers in Pulmonary and Respiratory Medicine. Recurrent topics in David A. Long's work include Renal and related cancers (18 papers), Chronic Kidney Disease and Diabetes (13 papers) and Renal Diseases and Glomerulopathies (12 papers). David A. Long is often cited by papers focused on Renal and related cancers (18 papers), Chronic Kidney Disease and Diabetes (13 papers) and Renal Diseases and Glomerulopathies (12 papers). David A. Long collaborates with scholars based in United Kingdom, United States and India. David A. Long's co-authors include Adrian S. Woolf, Luigi Gnudi, Rukshana Shroff, Karen Price, Catherine M. Shanahan, Maria Kolatsi‐Joannou, Richard J. Coward, Richard J. Johnson, Paul J.D. Winyard and Wei Mu and has published in prestigious journals such as Physiological Reviews, PLoS ONE and Development.

In The Last Decade

David A. Long

85 papers receiving 3.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Imaging intact human organs with local resolution of cellular structures using hierarchical phase-contrast tomography

2021 162 citations Daniyal J. Jafree, David A. Long et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
David A. Long United Kingdom	34	1.4k	1.2k	558	484	408	90	3.7k
James Tomlinson United Kingdom	25	1.1k 0.8×	207 0.2×	1.7k 3.0×	245 0.5×	546 1.3×	83	3.6k
Ronald Witteles United States	36	2.7k 1.9×	702 0.6×	494 0.9×	607 1.3×	2.1k 5.1×	157	5.3k
Abhijit Dasgupta United States	33	1.6k 1.2×	220 0.2×	414 0.7×	358 0.7×	200 0.5×	85	4.0k
Gregory D. Ayers United States	30	674 0.5×	280 0.2×	1.0k 1.8×	625 1.3×	158 0.4×	88	3.8k
Jonathan Barratt United Kingdom	45	944 0.7×	4.8k 3.9×	340 0.6×	751 1.6×	152 0.4×	291	6.6k
Thibaud Damy France	48	4.5k 3.2×	1.8k 1.5×	532 1.0×	1.0k 2.1×	2.9k 7.2×	263	7.5k
Kerstin Sandelin Sweden	40	1.2k 0.8×	935 0.8×	1.6k 2.8×	520 1.1×	55 0.1×	109	5.8k
David S. Geller United States	38	3.1k 2.2×	203 0.2×	1.8k 3.2×	1.7k 3.5×	826 2.0×	130	7.2k
Scott Murphy United States	33	449 0.3×	108 0.1×	400 0.7×	376 0.8×	410 1.0×	67	4.2k
T Haas Czechia	25	1.3k 0.9×	80 0.1×	682 1.2×	410 0.8×	198 0.5×	73	5.0k

Countries citing papers authored by David A. Long

Since Specialization

Citations

This map shows the geographic impact of David A. Long's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David A. Long with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David A. Long more than expected).

Fields of papers citing papers by David A. Long

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David A. Long. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David A. Long. The network helps show where David A. Long may publish in the future.

Co-authorship network of co-authors of David A. Long

This figure shows the co-authorship network connecting the top 25 collaborators of David A. Long. A scholar is included among the top collaborators of David A. Long based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David A. Long. David A. Long is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Long, David A., et al.. (2025). Neurite outgrowth inhibitor-B in physiology and disease. Physiological Reviews. 106(1). 239–280.

Arjun, Sapna, Idris Harding, Maria Kolatsi‐Joannou, et al.. (2024). SGLT1 contributes to glucose-mediated exacerbation of ischemia–reperfusion injury in ex vivo rat heart. Basic Research in Cardiology. 119(5). 733–749. 1 indexed citations

Morais, Mychel, Craig Lawless, Syed Murtuza Baker, et al.. (2022). Kidney organoids recapitulate human basement membrane assembly in health and disease. UCL Discovery (University College London). 28 indexed citations

Ingham, Neil J., Aara Patel, Lucy A. Anderson, et al.. (2022). The timing of auditory sensory deficits in Norrie disease has implications for therapeutic intervention. JCI Insight. 7(3). 10 indexed citations

Randles, Michael J., Franziska Lausecker, Hani Suleiman, et al.. (2021). Identification of an Altered Matrix Signature in Kidney Aging and Disease. Journal of the American Society of Nephrology. 32(7). 1713–1732. 51 indexed citations

Jafree, Daniyal J., David A. Long, Peter Scambler, & Christiana Ruhrberg. (2021). Mechanisms and cell lineages in lymphatic vascular development. Angiogenesis. 24(2). 271–288. 27 indexed citations

Pan, Jiaqi, Carlo Alberto Ricciardi, Xiaoyan Bai, et al.. (2019). Overexpression of Circulating Soluble Nogo-B Improves Diabetic Kidney Disease by Protecting the Vasculature. Diabetes. 68(9). 1841–1852. 16 indexed citations

Miller, Cynthia, et al.. (2018). Laying a Foundation: Four-Year Results from the National YouthBuild Evaluation.. MDRC. 8 indexed citations

Verma, Nandita, et al.. (2017). Learning from the Work Rewards Demonstration: Final Results from the Family Self-Sufficiency Study in New York City. SSRN Electronic Journal. 5 indexed citations

10.

Vasilopoulou, Elisavet, Maria Kolatsi‐Joannou, Maja T. Lindenmeyer, et al.. (2016). Loss of endogenous thymosin β4 accelerates glomerular disease. Kidney International. 90(5). 1056–1070. 26 indexed citations

11.

Randles, Michael J., Adrian S. Woolf, Jennifer L. Huang, et al.. (2015). Genetic Background is a Key Determinant of Glomerular Extracellular Matrix Composition and Organization. Journal of the American Society of Nephrology. 26(12). 3021–3034. 34 indexed citations

12.

Dessapt-Baradez, Cécile, Adrian S. Woolf, Kathryn White, et al.. (2013). Targeted Glomerular Angiopoietin-1 Therapy for Early Diabetic Kidney Disease. Journal of the American Society of Nephrology. 25(1). 33–42. 90 indexed citations

13.

Long, David A., Jill T. Norman, & Leon G. Fine. (2012). Restoring the renal microvasculature to treat chronic kidney disease. Nature Reviews Nephrology. 8(4). 244–250. 83 indexed citations

14.

Yates, Laura L., David A. Long, Paraskevi Goggolidou, et al.. (2010). The planar cell polarity gene Vangl2 is required for mammalian kidney-branching morphogenesis and glomerular maturation. Human Molecular Genetics. 19(23). 4663–4676. 97 indexed citations

15.

Hoefnagels, Mariëlle H., et al.. (2008). An Analysis of Calibrated Peer Review (CPR) in a Science Lecture Classroom. The journal of college science teaching. 37(4). 66–73. 40 indexed citations

16.

Price, Karen, Yuri Y. Sautin, David A. Long, et al.. (2006). Human Vascular Smooth Muscle Cells Express a Urate Transporter. Journal of the American Society of Nephrology. 17(7). 1791–1795. 110 indexed citations

17.

Burgu, Berk, Liam McCarthy, Vanita Shah, et al.. (2006). Vascular endothelial growth factor stimulates embryonic urinary bladder development in organ culture. British Journal of Urology. 98(1). 217–225. 18 indexed citations

18.

Long, David A., Wei Mu, Karen Price, et al.. (2006). Vascular endothelial growth factor administration does not improve microvascular disease in the salt-dependent phase of post-angiotensin II hypertension. American Journal of Physiology-Renal Physiology. 291(6). F1248–F1254. 12 indexed citations

19.

Long, David A., Mohammad Newaz, Sharma Prabhakar, et al.. (2005). Loss of nitric oxide and endothelial-derived hyperpolarizing factor-mediated responses in aging. Kidney International. 68(5). 2154–2163. 51 indexed citations

20.

Long, David A., Adrian S. Woolf, Toshio Suda, & Hai Tao Yuan. (2001). Increased Renal Angiopoietin-1 Expression in Folic Acid-Induced Nephrotoxicity in Mice. Journal of the American Society of Nephrology. 12(12). 2721–2731. 60 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact